Remember me
In the published article, there was an error in Table 3. In Row 2, Column 1, the manufacturer information for APB-R3 is incorrectly listed as “Sigma-Aldrich.” The corrected Table 3, Row 2, Column 1 appear below.
APB-R3 (AprilBio Co., Ltd.)
In Row 2, Column 4, the status of the study in Healthy Subjects was previously noted as “Ongoing Phase I study (NCT05715736).” The corrected Table 3, Row 2, Column 4, the fourth bullet appear below.
Healthy Subjects: Completed Phase I study (NCT05715736).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: IL-18, autoimmunity, asthma, inflammasome, eosinophilia
Citation: Thawanaphong S, Nair A, Volfson E, Nair P and Mukherjee M (2025) Corrigendum: IL-18 biology in severe asthma. Front. Med. 12:1558229. doi: 10.3389/fmed.2025.1558229
Received: 09 January 2025; Accepted: 10 January 2025;
Published: 21 January 2025.
Copyright © 2025 Thawanaphong, Nair, Volfson, Nair and Mukherjee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Manali Mukherjee, bXVraGVyakBtY21hc3Rlci5jYQ==
†These authors have contributed equally to this work
Comments (0)